Clinical Trials on Myelodysplastic Syndromes (MDS)
Total 34465 results
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
Cyclacel Pharmaceuticals, Inc.M.D. Anderson Cancer CenterCompleted
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
Goethe UniversityStichting Hemato-Oncologie voor Volwassenen Nederland; Polish Adult Leukemia... and other collaboratorsTerminatedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Germany, Netherlands
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
iOMEDICO AGCompleted
-
Peter L GreenbergAmgenCompletedMyelodysplastic Syndromes | Myelodysplastic Syndromes (MDS) | Blood CancerUnited States
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Longbio PharmaActive, not recruitingMyelodysplastic Syndrome (MDS)China
-
Otsuka Australia Pharmaceutical Pty LtdCompletedMyelodysplastic Syndrome (MDS)Australia
-
Yale UniversityWithdrawn
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Groupe Francophone des MyelodysplasiesNovartisCompleted
-
Gruppo Italiano Malattie EMatologiche dell'AdultoTerminated
-
Kyowa Kirin Co., Ltd.CompletedMDSJapan, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
Sunnybrook Health Sciences CentreHealth Sciences Centre, Winnipeg, Manitoba; The Ottawa Hospital; Jewish General... and other collaboratorsUnknownMyelodysplastic Syndrome (MDS)Canada
-
Astex Pharmaceuticals, Inc.CompletedMyelodysplastic Syndrome | MDSUnited States, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMyelodysplastic Syndrome | MDSUnited States
-
Aprea TherapeuticsTerminatedMyelodysplastic Syndromes | MDSUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedMyelodysplastic Syndromes | MDSUnited States
-
Dongzhimen Hospital, BeijingNot yet recruiting
-
Groupe Francophone des MyelodysplasiesNovartis; Neovii BiotechActive, not recruiting
-
Aprea TherapeuticsCompletedMDSUnited States, France
-
Rush University Medical CenterCelgene CorporationTerminated
-
AmgenCompletedMDSGermany, Italy, Belgium, Czechia, Switzerland, France, Austria, Greece, Spain
-
Helsinn Healthcare SACompletedMyelodysplastic Syndrome | MDSUnited States
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Japan
-
PureTechRecruiting
-
Anjali SharathkumarAmgenActive, not recruitingThrombocytopenia | Bone Marrow Failure Disorders | Aplastic Anemia | Refractory Cytopenia of Childhood | Myelodysplastic Syndrome(MDS)United States
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Anemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndromes (MDS) | Chronic Myelomonocytic Leukemia (CMML) | Low to Intermediate-1 MDSUnited States, France
-
Stanford UniversityNational Institutes of Health (NIH)CompletedMyelodysplastic Syndromes | Myeloproliferative Disorders | Myelodysplastic Syndromes (MDS) | Blood and Marrow Transplant (BMT) | Myeloproliferative Disorders (MPD)United States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingMyelodysplastic Syndrome (MDS) | Severe Aplastic Anemia | Hypo-Plastic MDSUnited States
-
Novartis PharmaceuticalsTerminated
-
M.D. Anderson Cancer CenterRecruitingB-Cell Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
Montefiore Medical CenterM.D. Anderson Cancer Center; Flamingo Therapeutics NVRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | AML/MDSUnited States
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
Gwynn Long, M.D.ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasm (MDS/MPN)United States
-
University of FloridaWithdrawnMyelodysplastic Syndromes | AML | Acute Leukemia | MDS
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)United Kingdom, Germany, Belgium
-
Assistance Publique - Hôpitaux de ParisUnknownInfection | Risk Factors | Myelodysplastic Syndrome (MDS) | IPSS High RiskFrance
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS
-
Jacqueline Garcia, MDNational Institutes of Health (NIH)RecruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant | MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable)United States
-
Sunnybrook Health Sciences CentreQueen's University; Ontario Molecular Pathology Research NetworkUnknownCardiovascular Diseases | Inflammation | MDSCanada
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia | MDS | Hematology
-
Peking University People's HospitalCompletedAdvanced MDS Without Identical Sibling DonorChina
-
Nanexa ABUppsala UniversityCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML)Sweden